Immune intervention with anti-CD3 in diabetes.
Harlan
David M
DM
von Herrath
Matthias
M
D000906:Antibodies / Q000627:therapeutic use*; D017252:CD3 Complex / Q000276:immunology*; D017322:Clinical Trials, Phase II as Topic; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy; D020031:Epstein-Barr Virus Infections / Q000209:etiology / Q000276:immunology; D004854:Herpesvirus 4, Human / Q000235:genetics; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007328:Insulin / Q000378:metabolism; D007515:Islets of Langerhans / Q000276:immunology / Q000378:metabolism; D011236:Prediabetic State / Q000276:immunology
D000906:Antibodies; D017252:CD3 Complex; D007328:Insulin